軟部組織修復の世界市場:種類別(メッシュ型組織、腹腔鏡器具、固定器具)、用途別(乳房再建、歯科用修復、硬膜修復、頭頸部用関連用品、ヘルニア修復、整形外科的治療、骨盤臓器脱・性器脱治療、皮膚の修復)

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top Winning Strategies

3.3. Porters Five Forces analysis
3.4. Market share analysis, 2016
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Surge in obese population
3.5.1.2. Rise in geriatric population
3.5.1.3. Increase in participation in sports activities and the rise in of soft tissue injuries

3.5.2. Restraints

3.5.2.1. Lack of reimbursement & high cost of soft tissue repair procedures
3.5.2.2. Unclear regulatory scenario

3.5.3. Opportunity

3.5.3.1. High potential of emerging economies and increase in demand for soft tissue repair products

CHAPTER 4: SOFT TISSUE REPAIR MARKET, BY TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Tissue mesh

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.4. Biological mesh

4.2.4.1. Market size and forecast
4.2.4.2. Allograft

4.2.4.2.1. Market size and forecast

4.2.4.3. Xenograft

4.2.4.3.1. Market size and forecast

4.2.5. Synthetic mesh

4.2.5.1. Market size and forecast

4.3. Laparoscopic instruments

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Fixation devices

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.4.4. Suture anchors

4.4.4.1. Market size and forecast

4.4.5. Interference screw

4.4.5.1. Market size and forecast

CHAPTER 5: SOFT TISSUE REPAIR MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Breast reconstruction

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. Dental repair

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

5.4. Dural repair

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country

5.5. Head and neck applications

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

5.6. Hernia repair

5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country

5.7. Orthopedic repair

5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by country

5.8. Pelvic & vaginal prolapse repair

5.8.1. Market size and forecast, by region
5.8.2. Market analysis, by country

5.9. Skin repair

5.9.1. Market size and forecast, by region
5.9.2. Market analysis, by country

CHAPTER 6: SOFT TISSUE REPAIR MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key trends and opportunities
6.2.2. North America market size and forecast, by country

6.2.2.1. U.S. market size and forecast, by type
6.2.2.2. U.S. market size and forecast, by application
6.2.2.3. Canada market size and forecast, by type
6.2.2.4. Canada market size and forecast, by application
6.2.2.5. Mexico market size and forecast, by type
6.2.2.6. Mexico market size and forecast, by application

6.2.3. North America market size and forecast, by type
6.2.4. North America market size and forecast, by application

6.3. Europe

6.3.1. Key trends and opportunities
6.3.2. Europe market size and forecast, by country

6.3.2.1. Germany market size and forecast, by type
6.3.2.2. Germany market size and forecast, by application
6.3.2.3. France market size and forecast, by type
6.3.2.4. France market size and forecast, by application
6.3.2.5. UK market size and forecast, by type
6.3.2.6. UK market size and forecast, by application
6.3.2.7. Italy market size and forecast, by type
6.3.2.8. Italy market size and forecast, by application
6.3.2.9. Spain market size and forecast, by type
6.3.2.10. Spain market size and forecast, by application
6.3.2.11. Rest of Europe market size and forecast, by type
6.3.2.12. Rest of Europe market size and forecast, by application

6.3.3. Europe market size and forecast, by type
6.3.4. Europe market size and forecast, by application

6.4. Asia-Pacific

6.4.1. Key trends and opportunities
6.4.2. Asia-Pacific market size and forecast, by country

6.4.2.1. Japan market size and forecast, by type
6.4.2.2. Japan market size and forecast, by application
6.4.2.3. China market size and forecast, by type
6.4.2.4. China market size and forecast, by application
6.4.2.5. India market size and forecast, by type
6.4.2.6. India market size and forecast, by application
6.4.2.7. Australia market size and forecast, by type
6.4.2.8. Australia market size and forecast, by application
6.4.2.9. Singapore market size and forecast, by type
6.4.2.10. Singapore market size and forecast, by application
6.4.2.11. Rest of Asia-Pacific market size and forecast, by type
6.4.2.12. Rest of Asia-Pacific market size and forecast, by application

6.4.3. Asia-Pacific market size and forecast, by type
6.4.4. Asia-Pacific market size and forecast, by application

6.5. LAMEA

6.5.1. Key trends and opportunities
6.5.2. LAMEA market size and forecast, by country

6.5.2.1. Brazil market size and forecast, by type
6.5.2.2. Brazil market size and forecast, by application
6.5.2.3. Turkey market size and forecast, by type
6.5.2.4. Turkey market size and forecast, by application
6.5.2.5. Saudi Arabia market size and forecast, by type
6.5.2.6. Saudi Arabia market size and forecast, by application
6.5.2.7. South Africa market size and forecast, by type
6.5.2.8. South Africa market size and forecast, by application
6.5.2.9. Rest of LAMEA market size and forecast, by type
6.5.2.10. Rest of LAMEA market size and forecast, by application

6.5.3. LAMEA market size and forecast, by type
6.5.4. LAMEA market size and forecast, by application

CHAPTER 7: COMPANY PROFILES

7.1. Allergan Plc. (LifeCell Corporation)

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.3.1. Business performance
7.1.4. Key strategic moves and developments

7.2. Athersys, Inc.

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Business performance
7.2.5. Key strategic moves and developments

7.3. CryoLife, Inc.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Business performance

7.4. Integra Lifesciences Corporation

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves and developments

7.5. Medtronic Plc.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Business performance
7.5.5. Key strategic moves and developments

7.6. Organogenesis Inc.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Key strategic moves and developments

7.7. Stryker Corporation

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Business performance
7.7.5. Key strategic moves and developments

7.8. Zimmer Biomet Holdings, Inc.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Business performance
7.8.5. Key strategic moves and developments

7.9. Smith & Nephew plc.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves and developments

7.10. Becton, Dickinson and Company (C.R. Bard)

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Business performance

facebooktwittergoogle_plusredditpinterestlinkedinmail